JP2014522856A - アルテロランおよびピペラキンの安定した投与形態物 - Google Patents

アルテロランおよびピペラキンの安定した投与形態物 Download PDF

Info

Publication number
JP2014522856A
JP2014522856A JP2014519689A JP2014519689A JP2014522856A JP 2014522856 A JP2014522856 A JP 2014522856A JP 2014519689 A JP2014519689 A JP 2014519689A JP 2014519689 A JP2014519689 A JP 2014519689A JP 2014522856 A JP2014522856 A JP 2014522856A
Authority
JP
Japan
Prior art keywords
dosage form
active compound
piperaquine
blend
blending
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014519689A
Other languages
English (en)
Japanese (ja)
Inventor
イーノス，アーノ，アッパボー
マダン，ハリシュ，クマー
マダン，スミット
トレハン，アヌパム
チャギ，プニート
アローラ，ヴィノード，クマー
ロイ，アルジュン
バタチャリア，サンジュクタ
Original Assignee
ランバクシー ラボラトリーズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/183,119 external-priority patent/US8664265B2/en
Application filed by ランバクシー ラボラトリーズ リミテッド filed Critical ランバクシー ラボラトリーズ リミテッド
Publication of JP2014522856A publication Critical patent/JP2014522856A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2014519689A 2011-07-14 2012-07-13 アルテロランおよびピペラキンの安定した投与形態物 Pending JP2014522856A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13/183,119 2011-07-14
US13/183,119 US8664265B2 (en) 2005-05-18 2011-07-14 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
IN2703/DEL/2011 2011-09-19
IN2703DE2011 2011-09-19
IN2156/DEL/2012 2012-07-12
IN2156DE2012 2012-07-12
PCT/IB2012/053614 WO2013008218A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Publications (1)

Publication Number Publication Date
JP2014522856A true JP2014522856A (ja) 2014-09-08

Family

ID=47505579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014519689A Pending JP2014522856A (ja) 2011-07-14 2012-07-13 アルテロランおよびピペラキンの安定した投与形態物

Country Status (10)

Country Link
EP (1) EP2731603A1 (OSRAM)
JP (1) JP2014522856A (OSRAM)
KR (1) KR20140053169A (OSRAM)
CN (1) CN103930107A (OSRAM)
AP (1) AP2014007413A0 (OSRAM)
AU (1) AU2012282077A1 (OSRAM)
CA (1) CA2850089A1 (OSRAM)
EA (1) EA201490233A8 (OSRAM)
MX (1) MX2014000463A (OSRAM)
WO (1) WO2013008218A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017226643A (ja) * 2016-06-20 2017-12-28 ヨン ヨ，オ キニーネ塩懸濁液を含む抗癌治療のための局所投与用注射剤組成物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014132226A1 (en) 2013-02-28 2014-09-04 Ranbaxy Laboratories Limited Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
MX2020006055A (es) * 2017-12-12 2020-08-20 Intervet Int Bv Composiciones farmaceuticas implantables de isoxazolina y usos de las mismas.
TW202220645A (zh) * 2020-08-14 2022-06-01 印度商太陽製藥工業有限公司 用於治療瘧疾的固定劑量組合藥物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
EP1898901B1 (en) * 2005-05-18 2016-11-23 Sun Pharmaceutical Industries Limited Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
CN101472582A (zh) * 2006-05-17 2009-07-01 兰贝克赛实验室有限公司 联用合成青蒿素衍生物和双喹啉衍生物的抗疟疗法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017226643A (ja) * 2016-06-20 2017-12-28 ヨン ヨ，オ キニーネ塩懸濁液を含む抗癌治療のための局所投与用注射剤組成物
JP7105465B2 (ja) 2016-06-20 2022-07-25 ヨン ヨ，オ キニーネ塩懸濁液を含む抗癌治療のための局所投与用注射剤組成物及び懸濁液注射剤の製造方法

Also Published As

Publication number Publication date
MX2014000463A (es) 2014-07-09
AP3777A (OSRAM) 2016-08-31
EP2731603A1 (en) 2014-05-21
AP2014007413A0 (en) 2014-02-28
CA2850089A1 (en) 2013-01-17
EA201490233A8 (ru) 2015-01-30
CN103930107A (zh) 2014-07-16
AU2012282077A1 (en) 2014-01-30
EA201490233A1 (ru) 2014-07-30
WO2013008218A1 (en) 2013-01-17
KR20140053169A (ko) 2014-05-07

Similar Documents

Publication Publication Date Title
RU2328274C2 (ru) Препарат ламотриджин с контролируемым высвобождением
JP7023945B2 (ja) レナリドミドの経口用錠剤組成物
US8664265B2 (en) Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
WO2012029348A1 (ja) 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
RU2505286C1 (ru) Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения
JP2020500870A (ja) 乳酸カルシウム組成物および使用法
WO2004056336A2 (en) Controlled release, multiple unit drug delivery systems
JP2023071923A (ja) レナリドミドの経口用コーティング錠剤組成物
AU2012326976B2 (en) Sustained-release preparation
EP2310385B1 (en) Solid pharmaceutical composition
WO2022208156A1 (en) Pharmaceutical composition of molnupiravir
WO2019130749A1 (ja) 新規微粒子コーティング（薬物含有中空粒子及びその製法）
US8470365B2 (en) Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
CN103930107A (zh) 青蒿氧烷和哌喹的稳定剂型
RU2694056C2 (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
EP3854386A1 (en) An orally disintegrating pharmaceutical composition comprising nefopam and process for preparing the same
RU2665372C2 (ru) Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
US10335376B2 (en) Raloxifene sprinkle composition
KR102391495B1 (ko) 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제
WO2014132226A1 (en) Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
JP2010013481A (ja) アムロジピン含有粒子およびそれからなる口腔内崩壊錠
OA16845A (en) Stable dosage forms of arterolane and piperaquine
RU2543322C1 (ru) Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения
EP3335701A1 (en) Pharmaceutical composition comprising omarigliptin
KR20180002437A (ko) 독실아민 및 피리독신을 포함하는 약제학적 복합 제제